Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy ; volume:22 ; number:1 ; day:8 ; month:11 ; year:2021 ; pages:1-15 ; date:12.2021
Trials ; 22, Heft 1 (8.11.2021), 1-15, 12.2021
- Urheber
-
Daskalakis, Zafiris J.
Tamminga, Carol
Throop, Alanah
Palmer, Lucy
Dimitrova, Julia
Farzan, Faranak
Thorpe, Kevin E.
McClintock, Shawn M.
Blumberger, Daniel M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-021-05730-7
- URN
-
urn:nbn:de:101:1-2022021820023646171213
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Daskalakis, Zafiris J.
- Tamminga, Carol
- Throop, Alanah
- Palmer, Lucy
- Dimitrova, Julia
- Farzan, Faranak
- Thorpe, Kevin E.
- McClintock, Shawn M.
- Blumberger, Daniel M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Magnetic seizure therapy and electroconvulsive therapy increase aperiodic activity
Severe bradycardia at the termination of seizure during electroconvulsive therapy
Amplitude-determined seizure-threshold, electric field modeling, and electroconvulsive therapy antidepressant and cognitive outcomes
The influence of anaesthetic choice on seizure duration of electroconvulsive therapy; etomidate versus methohexital
Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): protocol for identification of novel biomarkers via neurophysiology
How electroconvulsive therapy works in the treatment of depression: is it the seizure, the electricity, or both?
Intravenous theophylline is the most effective intervention to prolong EEG seizure duration in patients undergoing electroconvulsive therapy
Intravenous theophylline is the most effective intervention to prolong EEG seizure duration in patients undergoing electroconvulsive therapy
Allopregnanolone and progesterone in relation to a single electroconvulsive therapy seizure and subsequent clinical outcome: an observational cohort study
Assessment of seizure duration and utility of using SedLine® EEG tracing in veterans undergoing electroconvulsive therapy: a retrospective analysis
Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality
Magnetic seizure therapy and electroconvulsive therapy increase aperiodic activity
Severe bradycardia at the termination of seizure during electroconvulsive therapy
Amplitude-determined seizure-threshold, electric field modeling, and electroconvulsive therapy antidepressant and cognitive outcomes
The influence of anaesthetic choice on seizure duration of electroconvulsive therapy; etomidate versus methohexital
Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): protocol for identification of novel biomarkers via neurophysiology
How electroconvulsive therapy works in the treatment of depression: is it the seizure, the electricity, or both?
Intravenous theophylline is the most effective intervention to prolong EEG seizure duration in patients undergoing electroconvulsive therapy
Intravenous theophylline is the most effective intervention to prolong EEG seizure duration in patients undergoing electroconvulsive therapy
Allopregnanolone and progesterone in relation to a single electroconvulsive therapy seizure and subsequent clinical outcome: an observational cohort study
Assessment of seizure duration and utility of using SedLine® EEG tracing in veterans undergoing electroconvulsive therapy: a retrospective analysis
Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality
Magnetic seizure therapy and electroconvulsive therapy increase aperiodic activity
Severe bradycardia at the termination of seizure during electroconvulsive therapy
Amplitude-determined seizure-threshold, electric field modeling, and electroconvulsive therapy antidepressant and cognitive outcomes
The influence of anaesthetic choice on seizure duration of electroconvulsive therapy; etomidate versus methohexital
Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): protocol for identification of novel biomarkers via neurophysiology
How electroconvulsive therapy works in the treatment of depression: is it the seizure, the electricity, or both?
Intravenous theophylline is the most effective intervention to prolong EEG seizure duration in patients undergoing electroconvulsive therapy
Intravenous theophylline is the most effective intervention to prolong EEG seizure duration in patients undergoing electroconvulsive therapy
Allopregnanolone and progesterone in relation to a single electroconvulsive therapy seizure and subsequent clinical outcome: an observational cohort study
Assessment of seizure duration and utility of using SedLine® EEG tracing in veterans undergoing electroconvulsive therapy: a retrospective analysis